PACT conducts randomized, controlled clinical trials to evaluate existing or new medications, combinations of medications, and defined management strategies for patients with PF.
The vision of PACT is to reduce the morbidity and mortality associated with pulmonary fibrosis and improve the quality of life for people living with pulmonary fibrosis, their carers and families in Australia through the facilitation and coordination of high quality clinical research.
Professor Dan Chambers talks about the PACT collaboration which includes the CRE-PF, leading PF specialists and Lung Foundation Australia here.
The specific objectives of PACT are:
Determining the place of rehabilitation in PF care is an example of a clinical trial for PACT. We are conducting a world-first randomised controlled trial of pulmonary rehabilitation to improve quality of life for those with pulmonary fibrosis in a project known as HIIT.
The PACT Network has announced the second annual PACT Grant-in-Aid for Investigator-led Pulmonary Fibrosis Clinical Research. There is to be ONE (1) Grant-in-Aid opportunity valued at up to AUD30,000 to assist investigator led Pulmonary Fibrosis clinical research. Applications have now closed and are under review.
To find out more click here.